Hyderabad Telangana, India

Subba Reddy Peketi


Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:


Years Active: 2017-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Subba Reddy Peketi: Innovator in Pharmaceutical Development

Introduction

Subba Reddy Peketi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Molnupiravir, a medication that has garnered attention for its potential in treating viral infections. With a total of four patents to his name, Peketi's work exemplifies innovation in drug formulation and process optimization.

Latest Patents

Among his latest patents, Peketi has developed pharmaceutical polymorphs of Molnupiravir. This invention provides both crystalline and amorphous forms of Molnupiravir, along with methods for their preparation. Additionally, he has patented a process for the preparation of Molnupiravir, which focuses on an improved and commercially viable method that ensures high yield and purity.

Career Highlights

Subba Reddy Peketi is currently associated with Optimus Drugs Private Limited, where he continues to advance his research and development efforts. His work has not only contributed to the scientific community but has also aimed at enhancing the availability of effective treatments in the pharmaceutical market.

Collaborations

Peketi has collaborated with several professionals in his field, including Srinivas Reddy Desi Reddy and Dnyandev Ragho Rane. These collaborations have played a crucial role in the successful development of his innovative pharmaceutical solutions.

Conclusion

Subba Reddy Peketi stands out as a prominent inventor in the pharmaceutical industry, with a focus on improving drug formulations and processes. His contributions, particularly in the development of Molnupiravir, highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…